When the Sjöberg Foundation recently distributed research grants in the area of difficult-to-treat cancer with a poor prognosis, three of the total of nine grants funded went to projects at Sahlgrenska Academy and Sahlgrenska University Hospital. Jonas Nilsson receives SEK 5 million for his project on CAR-T cell treatment for treatment-resistant skin and uveal melanoma. Göran Stenman receives SEK 3 million for the development of a new targeted treatment for patients with the therapy-resistant and deadly cancer form adenoid cystic cancer. Karin Sundfeldt receives SEK 4 million for the development of a screening tool for ovarian cancer that greatly may reduce mortality from the disease.
Sahlgrenska akademins nyheter
New additions to Future Faculty’s management
New marker predicts benefit of radiotherapy for early-stage breast cancer
They are proposed to be part of the next faculty board
Perception of negative gender discrimination common among medical students
Expanding knowledge about spinal cord injuries
The construction of the new BoIC lab at Sahlgrenska is underway
An outstanding microscope for new possibilities at CCI
Se seminarierna från Engineering Health 2021 i efterhand
The Royal Swedish Academy of Sciences releases a publication on vaccines
Leave a Comment